States. An unidentified agent was cultured from the stool of an infant who presented with FUO. This virus showed growth in HFDK cells and suckling mice. Using DNase sequence-independent single-primer amplification, we identified several nucleotide sequences with a high homology to Theiler's murine encephalomyelitis virus. Nearly full-length viral genome sequencing and phylogenetic analysis demonstrate that this virus is a member of the Cardiovirus genus of the Picornaviridae family.
liters of the ligation reaction mixture was used as a template in a 50-l PCR mixture containing 25 pmol of NBam24, 1ϫ Takara buffer, 0.8 mM dNTPs, and 2.5 units of Takara Ex Taq. The PCR mixture was heated to 72°C for 3 min before the addition of Takara Ex Taq. The mixture was then heated for an additional 5 min at 72°C to generate the primer-binding sites. Cycling conditions were as follows: 94°C for 1 min and 72°C for 3 min for 40 cycles.
Analysis of amplified DNA. Amplified PCR products were analyzed by polyacrylamide gel electrophoresis (PAGE). The distinct DNA bands seen by PAGE were excised and pooled. DNA from the pooled PAGE bands from each sample were purified and subcloned into pCR-II-TOPO (Invitrogen, Carlsbad, CA). Because excised DNA bands were pooled prior to subcloning, we were unable to relate each sequence to a particular PAGE band. Plasmids containing inserts were purified and sequenced using the T7 sequencing primer. We sequenced our cloned and uncloned PCR fragments by using a Big Dye terminator, version 3.1, sequencing kit (Amersham Pharmacia Biotechnology) and an ABI Prism 3130x genetic analyzer (Applied BioSystems) according to the manufacturers' instructions.
Amplification of the SAF-V genome. To amplify regions of SAF-V flanking the sequences that we found, we designed primers based on an alignment of TMEV (X56019), Theiler-like virus (AB090161), mengovirus (L22089), and EMCV (M81861), using Primer Premier, version 5.0, software (Palo Alto, CA). All amplicons were then sequenced using primer walking. The 5Ј end of SAF-V was found using a kit for the 5Ј rapid amplification of cDNA ends (Invitrogen) according to the manufacturer's instructions.
Phylogenetic analysis of the SAF-V genome. Phylogenetic analysis was performed using sequences representing full-length genomes of virus species representing all genera of the Picornaviridae. Sequences of all recognized individual virus species were included in the analysis except for the members of the Enterovirus genus, for which participation in the analysis was limited to the two most divergent members of the genus for presentation purposes. Picornavirus sequences for echovirus 5 (accession number AF083069), human rhinovirus 1B (D00239), porcine enterovirus 8 (AF406813), human hepatitis virus type A (M20273), simian hepatitis A virus (D00924), avian encephalomyelitis virus (AJ225173), Ljungan virus (AF327921), human parechovirus 2 (AJ005695), echovirus 22 (L02971), echovirus 23 (AF055846), mengovirus (L22089), EMCV (X87335), TMEV (M20562), Theiler-like virus NGS910 (AB090161), foot-andmouth disease virus (AF308157), equine rhinovirus type 1 (X96870), Aichi virus (AB040749), porcine teschovirus (AF231769), porcine enterovirus 1 (AJ011380), equine rhinovirus 3 (AF361253), and equine rhinovirus type 2 (X96871) were retrieved from the GenBank and aligned using the CLUSTALX program (24) . A neighbor-joining tree based on nucleotide distances with the Jukes-Cantor correction and pair-wise gap deletions with bootstrap resampling (100 replicates) was constructed using the MEGA3 software (13) . More detailed phylogenetic analysis was performed for each genomic region (5Ј and 3Ј untranslated regions [UTRs], leader peptide, and the proteins VP1 to VP4, 2A to 2C, and 3A to 3D) of cardioviruses. For the Vilyuisk virus, no full-length genome sequence is available. Therefore, we used sequence M94868 in the analysis of homologous regions. Noncoding regions of cardioviruses were aligned at the nucleotide level, and coding regions were aligned at the amino acid level and then back-translated to the nucleotide sequences using the CLUSTALW program as implemented in the BioEdit program (8) . For each region, phylogenetic trees were built with bootstrap resampling (100 replications) using the MEGA3 program and based on nucleotide p-distances for noncoding regions and on amino acid p-distances for coding regions. Nucleotide and amino acid similarities between the sequences of the SAF-V and other cardioviruses were calculated by the MEGA3 program. To check whether the SAF-V is a recombinant of known viruses, recombination analysis was performed using the bootscan method of the SimPlot program (http://sray.med.som.jhmi.edu/SCRoftware/).
Nucleotide sequence accession number. The sequence of the SAF-V has been deposited in the GenBank database under accession number EF165067.
RESULTS
Patient presents with FUO. In November 1981 an 8-monthold infant presented with FUO 24 days after the onset of symptoms. A stool sample was taken from the patient and cultured at the San Diego County Public Health Laboratory. Because the laboratory was unable to determine the agent, the culture was subsequently sent to the VRDL for more thorough characterization. There, a viral agent was observed that grew well in HFDK cells and in suckling mice and weakly in HFDL (human fetal diploid lung) cells and was unable to grow in PMK, A549, BSC, and RD cells (Table 1) . Electron microscopy showed the virus to be 28 to 30 nm in diameter and acid stable (data not shown). However, this methodology alone was insufficient to identify the virus.
Molecular detection of new picornavirus. Different segments of the genome of this unknown virus were amplified nonspecifically using DNase-SISPA (Materials and Methods). The viral isolate that we used to acquire our sequence data was cultured in HFDK cells. DNase-SISPA is useful in that it does not require prior sequence knowledge (11) . The PCR products were analyzed by PAGE (Fig. 1 ). This yielded several distinct bands ( Fig. 1 ), which we subcloned and sequenced. When we analyzed these sequences with BLASTn (which searches for sequence homology on a nucleotide level), there was no significant similarity to a virus. However, using tBLASTx (which compares all possible [six-frame] translations of a nucleotide sequence against all possible [six-frame] translations of a nucleotide sequence database), all of our nucleotide sequences showed a strong similarity to Theiler-like virus, which is a member of the cardiovirus genus in the Picornaviridae family.
Cloning of new picornavirus. To amplify the novel picornavirus genome, which we have provisionally named SAF-V, we used several different strategies. To amplify regions of the genome surrounding the sequences that we found, we designed primers based on the DNase-SISPA acquired sequence and an FIG. 1. DNase-SISPA amplification of tissue culture sample containing SAF-V. PCR products were analyzed on a 6.5% acrylamide gel. Lane L contains molecular size markers in base pairs. 
Molecular characteristics of SAF-V.
The genetic organization of SAF-V is similar to that of other cardioviruses since it has one open reading frame (ORF) that has 13 cleavage sites in its genome, which should separate the viral polypeptide into the following proteins: L, VP4, VP2, VP3, VP1, 2A, 2B, 2C, 3A, 3B, 3C, and 3D (Fig. 2) .
Overall, the Theiler-like virus genome had the highest nucleotide identity to SAF-V of any cardiovirus. Specifically, the 5Ј UTRs of SAF-V and Theiler-like virus were most similar (85%) in nucleotide identity (Table 2) . Moreover, except for VP1 of Vilyuisk virus, the proteins of Theiler-like virus had the highest amino acid identity to those of SAF-V of any of the cardiovirus proteins (Table 3) .
The coding region for the L protein of SAF-V has 64% nucleotide identity to the coding regions of the L proteins of Theiler-like virus and TMEV ( Table 2 ). The L protein of SAF-V contains the zinc finger and the acidic domains that are present in all sequenced cardioviruses (2; Fig. 3) . Furthermore, the Ser/Thr domain is partially deleted and contains one threonine codon in this domain which has the potential to be phosphorylated (Fig. 3) .
It has been reported that the L* protein exists in persistent strains of TMEV such as DA yet not in the neurovirulent strains GDVII and FA (17) . We identified an L* protein coding region in SAF-V (Fig. 2) . It is highly improbable that the C* ORF encodes a protein, because it has ACG as its start codon. In contrast to the L* protein of TMEV strain DA, which has 156 amino acids, the L* ORF of SAF-V encodes 57 amino acids and is 31% similar to the first 62 amino acids of the TMEV L* protein (data not shown). Nevertheless, we do not know if this ORF codes for a protein.
The EF loop structure of cardioviruses, associated with virulence, is located in the VP2 protein. Specifically, there are two loops within the larger loop structure. The first part of the SAF-V EF loop structure is unique since it has only 2 amino acid identities to other cardioviruses (Fig. 4) . In contrast, the second loop of SAF-V has 7 of 18 (39%) amino acid identities to the second loops of Theiler-like virus and Vilyuisk virus (Fig. 4) . Interestingly, there is an insertion in the middle of the second loop of the SAF-V EF loop, which is not found in any other cardiovirus VP2 protein (Fig. 4) . The CD loop structure of cardioviruses, also associated with virulence, is located in the VP1 protein. The first of the two SAF-V CD loops has no amino acid identity to other cardioviruses, and the second half of the loop is deleted (Fig. 5) . The second CD loop of Theilerlike virus and Vilyuisk virus has 47% (8/17) and 39% (7/17) amino acid identity to the second CD loop of SAF-V, respectively. Taken together this suggests that the structure of SAF-V is unlike all known cardioviruses.
Phylogenetic analysis of SAF-V. To establish the evolutionary relationship of SAF-V to other picornaviruses, phyloge- netic analysis of the genomes from all known members of the Picornaviridae family was performed (Fig. 6 ).
Our analysis indicated that SAF-V was closely related to the Theiler-like virus, which is a member of the genus Cardiovirus (Fig. 6A) . The next most closely related virus was TMEV, followed by mengovirus and EMCV, all members of the Cardiovirus genus (Fig. 6A) . Phylogenetic analyses of each genomic region confirmed these relationships (Fig. 6B) . Recombination analysis using the bootscan method was also performed on SAF-V to determine if it was a recombinant of other known picornaviruses (Fig. 7) . As SAF-V is a new member of the Picornaviridae family, there are many moderatelength genetic regions within the SAF-V genome that were similar to the Theiler-like virus and TMEV (Fig. 7) . However, the short length of these regions of similarity and the low bootstrap support for these associations suggested that SAF-V was not a recombinant. Our results therefore indicated that SAF-V is a unique member of the Picornaviridae family that is closely related to the four members of the Cardiovirus genus.
DISCUSSION
Here we characterized a novel human picornavirus, which we have provisionally named SAF-V, that was cultured from the stool of an infant who presented with FUO.
Molecular evolutionary analysis demonstrated that SAF-V is a new member of the Cardiovirus genus in the Picornaviridae family ( Fig. 6 and 7) . In the phylogenetic analysis of the fulllength genome sequences, SAF-V appeared to be most closely related to Theiler-like virus, followed by TMEV of mice and rats (Fig. 6A) . The only human virus related to the Theiler viruses identified so far was the Vilyuisk virus (15) . This virus, for which only short genetic regions have been sequenced, was known to be the most divergent virus within the Theiler group of viruses (Fig. 6B) . Our analysis of the genetic region for which amino acid sequence of the Vilyuisk virus is available demonstrated that SAF-V is closely related to the Theiler's group (Fig. 6B) . The bootstrap analysis of SAF-V demonstrated that this virus is not a recombinant of other known picornaviruses (Fig. 7) . Currently, two virus species are recognized among cardioviruses: EMCVs (mengovirus and EMCV, for which full-genome sequences are available, as well as Columbia SK and Maus Elberfeld viruses, which are not sequenced) and the Theiler virus species (TMEV, Theiler-like virus, and Vilyuisk virus) (23) . The demarcation criteria in the genus are that the members of a species share greater than 70% amino acid identity in the VP1, 2C, 3C, and 3D coding regions and that they share a natural host range. While our results demonstrated that the SAF-V is related to the Theiler virus species, its amino acid similarity in the VP1 region to the recognized members of the Theiler virus species is below 70% ( Table 2) .
The genetic organization of SAF-V is very similar to other cardioviruses. The SAF-V structural proteins VP1, VP2, VP3, and VP4 are in the same locations as those of TMEV (Fig. 2) . In addition, they are approximately the same size. Specifically, the loci of genes in SAF-V are more similar to Theiler virus species than the EMCV species (Fig. 2) , which is not surprising in light of the phylogenetic data. Since SAF-V does not have a poly(C) sequence in its 5Ј UTR, which is associated with virulence in EMCV (13), we would not expect SAF-V to be virulent. Conversely, the absence of a poly(C) sequence in the 5Ј UTR does not preclude SAF-V virulence (14, 26) .
The four loop structures that form the exterior of the cardiovirus surface are two small loops within the EF loop structure of VP2 and the two loops of the CD loop structure of VP1 (10) . The EF loop structure of SAF-V is unique since the second EF loop contains a 4-amino-acid insertion, and both loops combined contain no more than 26% amino acid identity to the EF loops of other cardioviruses (Fig. 4) . Similarly, the CD loop structure of SAF-V also has low homology to all other cardioviruses (0% in the first loop and 47% in the second to Theiler-like virus) as well as a 4-amino-acid deletion in the first loop. In contrast, TMEV has 63 and 44% amino acid identity to the first and second CD loops of Theiler-like virus, respectively. This suggests that the viral surface of SAF-V has a novel structure and possibly a different mechanism for infection. Furthermore, the primary sequences of the EF and CD loop structures in SAF-V do not offer any clues as to whether SAF-V is virulent like the GDVII strain of TMEV or persistent like TMEV strain DA.
Transmission of TMEV and EMCV occurs by the fecal-oral route (3, 22) . We do not know whether SAF-V caused the patient's fever; therefore, it is also difficult to hypothesize how or when the patient was infected with SAF-V. Since TMEV is pathogenic in mice, further investigation is under way to determine the prevalence of SAF-V in humans.
Because of the length of time between the illness and our molecular characterization, we do not know much about the patient's health around the time of initial infection (e.g., characteristics of the illness and/or length of symptoms beyond the 24th day) other than the fact that the stool sample was collected 24 days after the onset of FUO, which fits the clinical definition of FUO (21) . In addition, we do not know what other pathogens were tested for. However, SAF-V was the only agent isolated from the stool of the study subject. Nevertheless, we cannot claim that SAF-V is the etiological agent because we have not analyzed fecal samples from patients with FUO of known and unknown etiology.
We identified and characterized a new human virus, SAF-V, which was cultured from the stool of a pediatric patient presenting with FUO. SAF-V represents a new member of the genus Cardiovirus in the Picornaviridae family. The prevalence and pathogenicity of this virus remain to be determined.
